ETFs & Funds
Top Insider Trades 1/29/14: XLRN, AYR, SVVC, OPK $
Add a reply...
Latest StockTalks »
people get XLRN breaking news and analysis by email alert.
Get email alerts on XLRN »
Acceleron Pharma Inc.
Get latest price
From other sites
Analysts Confident In Acceleron Pharma's Drug Trial Outcomes
at Benzinga (Thu, 1:30PM)
Acceleron's Luspatercept Is All About Duration, And This Analyst Is Excited About Its Prospects
at Benzinga (Jun 13, 2016)
Zacks.com featured expert Kevin Matras highlights: Acceleron Pharma, Clear Channel Outdoor, Gulfport Energy and Earthlink Holdings
at Zacks.com (May 11, 2016)
Acceleron Pharma : Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
at 4-traders.com (Dec 5, 2015)
Interesting XLRN Put And Call Options For May 2016
at Nasdaq.com (Nov 6, 2015)